Our study has revealed that RelB inhibition causes a decrease in cellular ATP levels by reducing mitochondrial ATP production without affecting glycolytic ATP levels in a RelB-positive OxPhos-DLBCL cell line. This evidence concerns the gene RELB and diffuse large B-cell lymphoma.